Adiponectin in Youth
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Adiponectin is an adipose tissue protein that enhances insulin sensitivity and has antiatherogenic properties. The present study investigated the relationship of adiponectin levels in adolescents to 1) obesity and body fat distribution and 2) insulin sensitivity and the components of syndrome X. RESEARCH DESIGN AND METHODS—Twenty-three normal-weight and 26 obese adolescents had fasting adiponectin, lipid profile, and proinsulin measurements performed. Hepatic and peripheral insulin sensitivity were assessed with constant-rate [6,6-2H2]glucose infusion and a 3-h hyperinsulinemic-euglycemic clamp, respectively. Body composition was evaluated by dual-energy X-ray absorptiometry, and visceral adipose tissue (VAT) and subcutaneous adipose tissue were measured by computed tomography scan at the L4-L5 level. RESULTS—Obese adolescents had ∼50% lower adiponectin than normal-weight adolescents. Moreover, obese adolescents with high (111.8 ± 9.3 cm2) versus low (55.4 ± 2.1 cm2) VAT had lower adiponectin levels (6.2 ± 0.9 vs. 9.0 ± 1.0 μg/ml, P = 0.05). Plasma adiponectin correlated positively with peripheral and hepatic insulin sensitivity (r = 0.67, P < 0.001 and r = 0.54, P < 0.001, respectively) and HDL (r = 0.52, P < 0.001) and negatively with fasting proinsulin and the proinsulin-to-insulin ratio (r = −0.64, P < 0.001 and r = −0.43, P = 0.003, respectively). In a multiple regression analysis, adiponectin, independently and together with BMI, explained 73% (R2 = 0.73, P < 0.001) of the variance in insulin sensitivity. Adiponectin, but not adiposity, was the significant independent determinant of the proinsulin-to-insulin ratio (R2 = 0.18, P = 0.008) and of HDL (R2 = 0.45, P < 0.001). CONCLUSIONS—In summary, hypoadiponectinemia in youth is a strong and independent correlate of insulin resistance, β-cell dysfunction, visceral adiposity, and syndrome X. The antidiabetogenic and antiatherogenic properties of adiponectin are evident early in life and compromised in youth-onset obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,737
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,420
Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.8.1057 · Cited by 1,277
Yang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181
Epidemic Increase in Childhood Overweight, 1986-1998
Strauss, R. S. (2001) · JAMA · doi:10.1001/jama.286.22.2845 · Cited by 1,161
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
Cited by
Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.675355 · Cited by 2,882
Adipokines and Insulin Resistance
Rabe, K., Lehrke, M., Parhofer, K. G., & Broedl, U. C. (2008) · Molecular Medicine · doi:10.2119/2008-00058.rabe · Cited by 808
Mahabadi, A. A., Massaro, J. M., Rosito, G. A., Levy, D., Murabito, J. M., Wolf, P. A., O'Donnell, C. J., Fox, C. S., & Hoffmann, U. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn573 · Cited by 651
Adiponectin – a key adipokine in the metabolic syndrome
Whitehead, J. P., Richards, A. A., Hickman, I. J., Macdonald, G. A., & Prins, J. B. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00510.x · Cited by 644
Longitudinal study of physiologic insulin resistance and metabolic changes of puberty
Hannon, T. S., Janosky, J., & Arslanian, S. A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000246097.73031.27 · Cited by 353
“DOI: 10.1203/01.pdr.0000246097.73031.27 Abbreviations: GCRC, General Clinical Research Center; Ra, rate of appearance 759 testosterone levels 637–781 ng/dL).”
BackgroundMethodInfluentialSelf-citationBalagopal, P. (., de Ferranti, S. D., Cook, S., Daniels, S. R., Gidding, S. S., Hayman, L. L., McCrindle, B. W., Mietus-Snyder, M. L., & Steinberger, J. (2011) · Circulation · doi:10.1161/cir.0b013e31821c7c64 · Cited by 352
Maggio, C. A., & Pi-Sunyer, F. X. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00071-9 · Cited by 351
Adiponectin and cardiovascular health: an update
Hui, X., Lam, K. S., Vanhoutte, P. M., & Xu, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01395.x · Cited by 286
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U., & Stefan, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001765 · Cited by 282
Swarbrick, M. M., & Havel, P. J. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2007.0029 · Cited by 238
“66 While this relationship is not well supported by analyses of adiponectin mRNA expression, 51,67,68 in one study of 36 morbidly obese nondiabetic subjects it was reported that adiponectin mRNA expression in visceral fat, but not in subcutaneous fat, was positively correlated with the serum…”
Wijesekara, N., Krishnamurthy, M., Bhattacharjee, A., Suhail, A., Sweeney, G., & Wheeler, M. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085084 · Cited by 229
Després, J.-P. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul002 · Cited by 205
Relationship between adiponectin, obesity and insulin resistance
Balsan, G. A., Vieira, J. L. D. C., Oliveira, A. M. D., & Portal, V. L. (2015) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.61.01.072 · Cited by 196
Gungor, N., Bacha, F., Saad, R., Janosky, J., & Arslanian, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.638 · Cited by 186
“trol subjects were reported previously (6,7).”
BackgroundMethodInfluentialSelf-citationCruz, M. L., Shaibi, G. Q., Weigensberg, M. J., Spruijt-Metz, D., Ball, G. D. C., & Goran, M. I. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092625 · Cited by 176
“Although it remains unclear whether adipocytokines in children are simply markers of degree of adiposity, several recent reports have established significant relations between adipocytokines and insulin resistance that are independent of body composition (10, 172).”
BackgroundResultLee, S., Bacha, F., Gungor, N., & Arslanian, S. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.07.053 · Cited by 161
Self-citationArslanian, S. A., Bacha, F., Saad, R., & Gungor, N. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.115 · Cited by 138
“Insulin-stimulated glucose metabolism and insulin sensitivity and clearance were evaluated during a 3-h 40 mU m 2 min 1 hyperinsulinemiceuglycemic clamp according to our previously published methodology (20,21).”
BackgroundMethodSelf-citationIftikhar, I. H., Hoyos, C. M., Phillips, C. L., & Magalang, U. J. (2015) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4610 · Cited by 126
“51 The negative finding of CPAP on adiponectin is consistent with most but not all studies.”
Hamilton, J., Conwell, L., Syme, C., Ahmet, A., Jeffery, A., & Daneman, D. (2011) · International Journal of Pediatric Endocrinology · doi:10.1155/2011/417949 · Cited by 109
“They also received immediate notification of any serious adverse events.”
BackgroundLee, S., Gungor, N., Bacha, F., & Arslanian, S. (2007) · Diabetes Care · doi:10.2337/dc07-0203 · Cited by 105
“Biochemical Measurements The measurements of plasma glucose, insulin, lipids and adiponectin are described by us previously (18).”
Self-citationBacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2013) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00915.x · Cited by 106
“Fasting hepatic glucose production (HGP) was calculated during the last 30 min of the 2-h isotope infusion according to steady-state tracer dilution equations (16).”
MethodSelf-citationIn Vivo Insulin Sensitivity and Secretion in Obese Youth
Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2009) · Diabetes Care · doi:10.2337/dc08-1030 · Cited by 90
“5 mmol/l) as previously described (11).”
BackgroundMethodSelf-citationAdiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study
Patel, D. A., Srinivasan, S. R., Xu, J.-H., Chen, W., & Berenson, G. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.028 · Cited by 62
Metabolic flexibility and obesity in children and youth
Aucouturier, J., Duché, P., & Timmons, B. W. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00812.x · Cited by 43
“However, experimental techniques used to assess metabolic flexibility have already been used in a number of studies in obese children and youth (4,5).”
BackgroundMethod
Metadata
- Authors
- Bacha, F., Saad, R., Gungor, N., & Arslanian, S. A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2004-02-01
- Volume
- 27
- Issue
- 2
- Pages
- 547-552
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2034511899
- Cited by
- 278
- References
- 34
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.